Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05230693 · ClinicalTrials.gov registry record · NA
SPARC Smartphone Application for the Management of Sarcoidosis-Associated Fatigue
A NA study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT05230693: Completed NA study, sponsored by Medical University of South Carolina.
NCT05230693 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05230693, a NA study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
Fatigue is a pervasive and disabling symptom in sarcoidosis with limited treatment options. There is a significant association between heightened stress and sarcoidosis-associated fatigue. The proposed project will evaluate the usability/feasibility of a smartphone-based stress management application for the self-management of sarcoidosis-associated stress and fatigue.
Primary Outcome
Recruitment compared to number approached
Interventions
- BEHAVIORAL Enhanced Standard Care
- BEHAVIORAL Sarcoidosis Patient Assessment and Resource Companion App
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-02-23 |
| Est. Completion | 2023-07-25 |
| Phase | NA |
What the finished NCT05230693 record still lists
NCT05230693 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Enhanced Standard Care is the first listed.
NCT05230693 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05230693 about?
NCT05230693 is a clinical study titled "SPARC Smartphone Application for the Management of Sarcoidosis-Associated Fatigue". Fatigue is a pervasive and disabling symptom in sarcoidosis with limited treatment options. There is a significant association between heightened stress and sarcoidosis-associated fatigue. The proposed project will evaluate the usability/feasibility of a smartphone-based stress management applicatio...
What is the current status of trial NCT05230693?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2022-02-23. Estimated completion is 2023-07-25.
What interventions are being tested in trial NCT05230693?
The interventions under investigation include: Enhanced Standard Care (BEHAVIORAL), Sarcoidosis Patient Assessment and Resource Companion App (BEHAVIORAL).
Who is sponsoring clinical trial NCT05230693?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05230693's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI